INPACT – Innovative peptides against cancer and pathogenic bacteria aims to develop a platform technology to produce innovative peptide-based drugs that will be delivered to pharma industry for development and future clinical applications.



INPACT is focused in creating proof-of-concept. We aim to develop new generation drugs by producing chimeras that combine antitumoural, or antimicrobial, molecules with small domain antibodies and/or barrier-translocating chemical entities.